TMS Nearby

Spravato (Esketamine) in Prescott, Arizona

Compare 2 Spravato (Esketamine) clinics in Prescott, Arizona that offer care for treatment-resistant depression and major depressive disorder. Review services, ratings, and contact details to find the right provider near you.
Mental health clinic illustration

Clinics

2 clinics shown

  • Bob Stump Department of Veterans Affairs Medical Center

    The Bob Stump Department of Veterans Affairs Medical Center in Prescott serves veterans enrolled in VA healthcare, offering psychiatric services and mental health treatment as part of comprehensive medical care. The facility, located on Highway 89, provides medication management, psychotherapy, and crisis intervention for veterans with depression, PTSD, anxiety disorders, and substance use conditions. Specific availability of TMS, esketamine, or ketamine treatments at this location is not detailed in public listings; eligible veterans should contact the medical center directly to confirm procedural treatment options and referral pathways within the VA system.

    No reviews yet
    View Details

  • The Wellness Hub

    The Wellness Hub operates a mental health clinic in downtown Prescott on North Cortez Street, providing outpatient psychiatric services to adults in the area. The practice focuses on mental health evaluations and treatment planning, though specific modalities such as TMS, ketamine, or esketamine are not detailed in available information. Patients seeking specialized interventional treatments should contact the clinic directly to confirm current service offerings and insurance acceptance.

    No reviews yet
    View Details

About Spravato (Esketamine)

Spravato is the brand name for esketamine, an FDA-approved nasal spray for treatment-resistant depression and major depressive disorder with suicidal ideation. It's derived from ketamine and works on the brain's glutamate system — a different mechanism than traditional antidepressants like SSRIs.

Treatment is administered only at REMS-certified clinics under direct medical supervision. Patients self-administer the spray under a clinician's guidance, then remain at the clinic for at least two hours of monitoring after each dose. The induction phase typically involves twice-weekly sessions for four weeks, followed by weekly or biweekly maintenance dosing depending on response.

Many patients report meaningful symptom improvement within the first one to two weeks — substantially faster than the 4 to 8 weeks typical of oral antidepressants. Spravato is taken alongside an oral antidepressant, not as a replacement.

The most common side effects are dissociation, dizziness, sedation, and elevated blood pressure during and shortly after dosing. These typically resolve within the two-hour monitoring window. Patients cannot drive on the day of treatment.

Most commercial insurance and Medicare cover Spravato for treatment-resistant depression with prior authorization. Clinics offering Spravato in our directory hold active REMS certification and are staffed to provide the required in-clinic monitoring period.